92nd General Assembly
Status of SB1720
   [ Home ]   [ Back ]   [ Legislation ]
Please enter a bill number.

 Full Text  Bill Summary

   20 ILCS 2215/4-2          from Ch. 111 1/2, par. 6504-2                     

        Amends the Illinois Health Finance Reform Act. Provides that  the      
   Illinois  Health  Care  Cost  Containment  Council  shall  require any      
   pharmaceutical company that provides prescription drugs in Illinois to      
   disclose to the Council, in a manner and  fashion  designated  by  the      
   Council  by  rule,  all  prescription  drug  advertising and promotion      
   costs. Further provides that the Council must conduct  a  cost/benefit      
   analysis  to  determine  (i) the impact of these costs on prescription      
   drug prices and (ii) the impact on Illinois residents of any  increase      
   of  the prices and costs of prescription drugs that is attributable to      
   the advertising and promotional activities.                                 
   FEB-05-2002  S  FIRST READING                                                  
   FEB-05-2002  S  ADDED AS A CHIEF CO-SPONSOR              SMITH                 
   FEB-05-2002  S  REFERRED TO SENATE RULES COMMITTEE       RULES                 
   FEB-06-2002  S  ADDED AS A CHIEF CO-SPONSOR              HALVORSON             
   JAN-07-2003  S  SESSION SINE DIE                                               


 Full Text  Bill Summary